Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | ZTS | TAK | UTHR | NBIX |
| Company | Akebia Therapeutics | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.7700 | 163.76 | 13.04 | 359.50 | 134.98 |
| High | 1.8700 | 166.39 | 13.19 | 363.90 | 137.01 |
| Low | 1.7500 | 163.53 | 13.02 | 357.98 | 134.12 |
| Last | 1.8300 | 164.84 | 13.10 | 359.58 | 135.42 |
| Change | +0.0400 | +1.32 | +0.09 | -0.58 | +0.46 |
| % Change | +2.23% | +0.81% | +0.69% | -0.16% | +0.34% |
| Volume | 5,921,700 | 6,220,100 | 1,848,700 | 1,009,400 | 2,265,500 |
| 20-Day Average Volume | 2,350,265 | 2,630,775 | 1,570,355 | 326,945 | 1,009,850 |
| Previous Close | 1.7900 | 163.52 | 13.01 | 360.16 | 134.96 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9475 | 174.73 | 13.50 | 368.46 | 129.15 |
| 20-Day Raw Stochastic | 20.93% | 7.95% | 11.32% | 27.72% | 70.96% |
| 20-Day Relative Strength | 49.91% | 34.19% | 38.40% | 45.67% | 64.05% |
| Weighted Alpha | +19.22 | -16.12 | -8.76 | +58.67 | +5.06 |
| Today's Opinion | 72% Buy | 72% Sell | 88% Sell | 56% Buy | 24% Buy |
| Previous Opinion | 72% Buy | 72% Sell | 88% Sell | 56% Buy | 24% Buy |
| Last Month's Opinion | 88% Buy | 40% Sell | 40% Sell | 80% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.08% since 12/13/24 | -7.49% since 12/13/24 | -2.38% since 12/13/24 | -0.62% since 12/13/24 | +6.88% since 12/13/24 |
| Low | 1.7400 on 12/18/24 | 163.37 on 12/19/24 | 12.98 on 12/19/24 | 350.60 on 12/19/24 | 127.35 on 12/16/24 |
| High | 1.9000 on 12/18/24 | 179.29 on 12/16/24 | 13.42 on 12/17/24 | 383.00 on 12/18/24 | 140.00 on 12/18/24 |
| 1-Month | |||||
| %Chg | +2.23% since 11/20/24 | -6.16% since 11/20/24 | -1.43% since 11/20/24 | -1.30% since 11/20/24 | +9.84% since 11/20/24 |
| Low | 1.7400 on 12/18/24 | 163.37 on 12/19/24 | 12.98 on 12/19/24 | 350.60 on 12/19/24 | 122.37 on 11/21/24 |
| High | 2.1700 on 12/03/24 | 181.85 on 12/13/24 | 14.04 on 12/03/24 | 383.00 on 12/18/24 | 140.00 on 12/18/24 |
| 3-Month | |||||
| %Chg | +33.58% since 09/20/24 | -14.43% since 09/20/24 | -11.49% since 09/20/24 | +1.86% since 09/20/24 | +14.42% since 09/20/24 |
| Low | 1.2400 on 10/01/24 | 163.37 on 12/19/24 | 12.98 on 12/19/24 | 342.02 on 10/23/24 | 110.95 on 10/03/24 |
| High | 2.1700 on 12/03/24 | 197.51 on 09/27/24 | 14.92 on 09/23/24 | 417.82 on 11/08/24 | 140.00 on 12/18/24 |
| 6-Month | |||||
| %Chg | +94.68% since 06/20/24 | -1.99% since 06/20/24 | +3.89% since 06/20/24 | +16.38% since 06/20/24 | +1.01% since 06/20/24 |
| Low | 0.8000 on 06/26/24 | 163.37 on 12/19/24 | 12.60 on 06/21/24 | 308.08 on 06/21/24 | 110.95 on 10/03/24 |
| High | 2.1700 on 12/03/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 417.82 on 11/08/24 | 157.98 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 399,271 | 74,370,040 | 41,682,564 | 16,053,449 | 13,710,869 |
| Shares Outstanding, K | 218,181 | 451,165 | 3,181,875 | 44,645 | 101,247 |
| Annual Sales | 194,620,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -51,930,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 37,430,000 | 2,388,000,000 | 7,903,930,000 | 748,900,000 | 622,100,000 |
| Last Quarter Net Income | -20,040,000 | 682,000,000 | 618,620,000 | 309,100,000 | 129,800,000 |
| 60-Month Beta | 0.70 | 0.89 | 0.51 | 0.55 | 0.34 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/07/24 | 1.58 on 11/04/24 | 0.44 on 10/31/24 | 6.39 on 10/30/24 | 1.24 on 10/30/24 |
| Latest Earnings Date | 11/07/24 | 02/11/25 | 02/06/25 | 10/30/24 | 02/05/25 |
| Most Recent Dividend | N/A | 0.432 on 10/31/24 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 01/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.62 | 8.68 | 15.79 | 36.31 |